Literature DB >> 11442207

Effect of climatic factors and population density on varicella zoster virus epidemiology within a tropical country.

S Lolekha1, W Tanthiphabha, P Sornchai, P Kosuwan, S Sutra, B Warachit, S Chup-Upprakarn, Y Hutagalung, J Weil, H L Bock.   

Abstract

Blood samples were collected from healthy subjects, aged 9 months-29 years in urban and rural communities from 4 distinct regions in Thailand, to determine the seroprevalence rate of varicella-zoster virus (VZV) antibody and its relationship with demographic, climatic, and socioeconomic factors. The overall seroprevalence rate was 52.8% and increased from 15.5% in the 9-month to 4-year-old group to 75.9% in the 20-29 year-olds. The age-adjusted seroprevalence was significantly higher in the cooler than in the warmer regions. In the warmer regions only, the age-specific seroprevalence was significantly higher in the urban population than in the rural population. In Thailand, climate is the main determinant of VZV seroprevalence. The delayed onset of natural immunity is more marked in warmer climate areas. Population density is a secondary determinant; in the warmer areas, the pattern of adolescent and adult susceptibility was greater in rural than in urban areas.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11442207     DOI: 10.4269/ajtmh.2001.64.131

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  49 in total

Review 1.  Successes and challenges in varicella vaccine.

Authors:  Orestis Papaloukas; Georgia Giannouli; Vassiliki Papaevangelou
Journal:  Ther Adv Vaccines       Date:  2014-03

2.  Solar radiation and water vapor pressure to forecast chickenpox epidemics.

Authors:  D Hervás; J Hervás-Masip; A Nicolau; J Reina; J A Hervás
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-09-30       Impact factor: 3.267

3.  Serological Susceptibility to Varicella Among U.S. Immigration and Customs Enforcement Detainees.

Authors:  Aiden K Varan; Edith R Lederman; Shanon S Stous; Diana Elson; Jennifer L Freiman; Mona Marin; Adriana S Lopez; William M Stauffer; Rachael H Joseph; Stephen H Waterman
Journal:  J Correct Health Care       Date:  2017-09-25

4.  Low Varicella Zoster Virus Seroprevalence Among Young Children in the Democratic Republic of the Congo.

Authors:  Reena H Doshi; Vivian H Alfonso; Patrick Mukadi; Nicole A Hoff; Sue Gerber; Ado Bwaka; Stephen G Higgins; Cyrus Sinai; Brian Cowell; Guillaume Ngoie Mwamba; Emile Okitolonda; Jean-Jacques Muyembe-Tamfum; Anne W Rimoin
Journal:  Pediatr Infect Dis J       Date:  2018-02       Impact factor: 2.129

Review 5.  Epidemiology and factors influencing varicella infections in tropical countries including Sri Lanka.

Authors:  S W P Lakmini Daulagala; Faseeha Noordeen
Journal:  Virusdisease       Date:  2018-07-06

6.  Varicella-zoster virus at relapses of multiple sclerosis.

Authors:  Julio Sotelo; Graciela Ordoñez; Benjamin Pineda
Journal:  J Neurol       Date:  2007-03-31       Impact factor: 4.849

Review 7.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

8.  Outbreak of chickenpox in a refugee camp of northern Thailand.

Authors:  Yusuke Shimakawa; Olivier Camélique; Koya Ariyoshi
Journal:  Confl Health       Date:  2010-02-22       Impact factor: 2.723

9.  Identification of five major and two minor genotypes of varicella-zoster virus strains: a practical two-amplicon approach used to genotype clinical isolates in Australia and New Zealand.

Authors:  Vladimir N Loparev; Elena N Rubtcova; Vanda Bostik; Dhwani Govil; Christopher J Birch; Julian D Druce; D Scott Schmid; Margaret C Croxson
Journal:  J Virol       Date:  2007-09-26       Impact factor: 5.103

Review 10.  Varicella zoster virus infection.

Authors:  Anne A Gershon; Judith Breuer; Jeffrey I Cohen; Randall J Cohrs; Michael D Gershon; Don Gilden; Charles Grose; Sophie Hambleton; Peter G E Kennedy; Michael N Oxman; Jane F Seward; Koichi Yamanishi
Journal:  Nat Rev Dis Primers       Date:  2015-07-02       Impact factor: 52.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.